Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Bargo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 23, 2018
Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choicesJane L Wolstenholme, Danielle Bargo, Kay Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 25, 2017
Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modelingJacqueline Brown, Keziah Cook, Kelly Adamski, et al.
Journal of General Internal Medicine|November 20, 2025
Examining the Relationship Between Hospital Community Benefits and Community Social VulnerabilityHossein Zare, Darrell J Gaskin, Danielle Bargo, et al.
Anticancer Research|November 7, 2018
Sunitinib Treatment Modification in First-Line Metastatic Renal Cell Carcinoma: Analysis of the STAR-TOR RegistryMartin Boegemann, Marcus Hubbe, Despina Thomaidou, et al.
Inflammatory Bowel Diseases|September 28, 2019
Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United StatesMillie D Long, Timothy W Smith, Marco Dibonaventura, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With CancerXiaoliang Wang, Blythe J Adamson, Andrew Briggs, et al.
Journal of Medical Economics|October 21, 2020
Using electronic health record data to identify comparator populations for comparative effectiveness researchScott D Ramsey, Blythe J Adamson, Xiaoliang Wang, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2021
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative ColitisMillie D Long, Russell D Cohen, Timothy W Smith, et al.
BMC Cancer|December 21, 2018
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analysesIrina Proskorovsky, Agnes Benedict, Sylvie Negrier, et al.
BMC Gastroenterology|January 23, 2020
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and EuropeAlessandro Armuzzi, Miriam Tarallo, James Lucas, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 23, 2018
Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choicesJane L Wolstenholme, Danielle Bargo, Kay Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 25, 2017
Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modelingJacqueline Brown, Keziah Cook, Kelly Adamski, et al.
Journal of General Internal Medicine|November 20, 2025
Examining the Relationship Between Hospital Community Benefits and Community Social VulnerabilityHossein Zare, Darrell J Gaskin, Danielle Bargo, et al.
Anticancer Research|November 7, 2018
Sunitinib Treatment Modification in First-Line Metastatic Renal Cell Carcinoma: Analysis of the STAR-TOR RegistryMartin Boegemann, Marcus Hubbe, Despina Thomaidou, et al.
Inflammatory Bowel Diseases|September 28, 2019
Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United StatesMillie D Long, Timothy W Smith, Marco Dibonaventura, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With CancerXiaoliang Wang, Blythe J Adamson, Andrew Briggs, et al.
Journal of Medical Economics|October 21, 2020
Using electronic health record data to identify comparator populations for comparative effectiveness researchScott D Ramsey, Blythe J Adamson, Xiaoliang Wang, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2021
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative ColitisMillie D Long, Russell D Cohen, Timothy W Smith, et al.
BMC Cancer|December 21, 2018
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analysesIrina Proskorovsky, Agnes Benedict, Sylvie Negrier, et al.
BMC Gastroenterology|January 23, 2020
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and EuropeAlessandro Armuzzi, Miriam Tarallo, James Lucas, et al.
Pageof 2